What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Index level declines can reflect profit-taking, macro shocks, or sector rotations. This intro covers common indicators to read with context.
23,215 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
A bipartisan transparency push targets health disclosures and finances of aging lawmakers, signaling a receipt-check ...
A high-yield ETF promises sky-high payouts but posted negative returns over the last year as investors weigh the true...
Three ETFs are positioning investors for the next leg of AI-driven growth, offering diversified exposure as markets r...
If you could own one stock that steadily pays you more over time, what would it be? This article breaks down what mak...
Meme coins surged with viral fame, but a political push to bar elected officials from launching them could reshape th...
A viral moment at Wrigley Field sparked questions about safety and money. This guide shows smart budgeting, risk chec...
SoFi shareholders have faced a tough year, but a pair of upbeat bank results offers a new tailwind. This article brea...
When a fund trims large holdings, it can signal shifting risk and opportunity. This article explains why an investmen...
Energy Transfer is redefining growth in the energy sector. This article breaks down how the company sustains a moment...
Digital health is redefining care delivery and costs. This guide shows how to find a high-growth healthcare stock ear...
A longtime dividend grower is resurfacing in the spotlight after a 25% price pullback. With a higher-than-Treasury yi...